MHRA

News

More details have emerged of a UK plan for new medicines to get simultaneous decisions from the MHRA and NICE on their use by the NHS.

News

AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo

Market Access

The MHRA, will be running five pilot dialogues as part of its first year exploring a real-world evidence scientific dialogue programme.

News

Reports suggest a new framework for medicine reviews and a push to reduce NHS reliance on overseas-trained staff will feature in the 10-year plan.

News

The UK is studying cases of pancreatitis in people taking GLP-1 drugs for weight loss or type 2 diabetes to see if genetics may make them vulnerable.

News

Major changes to medical device regulations in the UK have come into force with an overhaul of post-market surveillance requirements.